About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Austin | 15,205 Studies Near You | Clareo Health

Clinical Trials LocationsAustin

Clinical Trials in Austin

Discover 15,205 clinical trials near Austin, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 14841-14860 of 15,205 trials

COMPLETEDNA< 1 mile

The Effect of Infant Feeding on Stool Characteristics

NCT00503789

Infants will be fed infant formula and stool characteristics assessed.

Mead Johnson Nutrition280 participantsStarted Aug 2007

Benton, Arkansas, United States • Conway, Arkansas, United States • Jonesboro, Arkansas, United States +20 more locations

COMPLETEDPhase 1< 1 mile

Study Evaluating the Effect of Food on the Bioavailability of PN400 Components

NCT00676442

We will evaluate the effect of food on the bioavailability of the components of PN400

POZEN24 participantsStarted May 2008

Austin, Texas, United States

Find Trials by Condition in Austin

Breast Cancerin Austin Lung Cancerin Austin Prostate Cancerin Austin Colorectal Cancerin Austin Melanomain Austin Leukemiain Austin Lymphomain Austin Pancreatic Cancerin Austin Ovarian Cancerin Austin Brain Cancerin Austin Diabetesin Austin

Data from ClinicalTrials.govTerms

TERMINATEDPhase 2/3< 1 mile

Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain

NCT00640705

The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be either the left or right ankle. The secondary purpose of this study is to assess the safety and tolerability of a diclofenac patch on the skin.

Cerimon Pharmaceuticals170 participantsStarted Jan 2008

Austin, Texas, United States

COMPLETEDPhase 2/3< 1 mile

Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis

NCT00640939

The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be one of the following: the affected shoulder, elbow, or wrist. The secondary purpose of this study is to assess the safety and tolerability of the diclofenac patch on the subject's skin, in the location being studied.

Rotator Cuff TendonitisBicipital TendonitisSubdeltoid Bursitis of the Shoulder+4 more

Cerimon Pharmaceuticals308 participantsStarted Dec 2007

Austin, Texas, United States

COMPLETEDPhase 2< 1 mile

Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration

NCT00259753

The objective of this study is to evaluate the safety and preliminary efficacy of three doses of Cand5. Cand5, a small interfering RNA molecule that selectively silences the mRNA encoding for VEGF.

Macular Degeneration

OPKO Health, Inc.120 participantsStarted Jul 2005

Phoenix, Arizona, United States • Tucson, Arizona, United States • Artesia, California, United States +20 more locations

COMPLETEDPhase 474 miles

Optimizing Prograf® Therapy in Renal Transplant Patients

NCT00297765

A study to determine the optimal dose and blood level of Prograf® in long-term maintenance of kidney transplant patients.

Renal Transplantation

Astellas Pharma Inc323 participantsStarted Jan 2003

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +39 more locations

COMPLETEDPhase 374 miles

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

NCT00103649

The purpose of this study is to assess xaliproden's potential capacity of slowing the deterioration of cognitive and global functions in patients with mild to moderate Alzheimer's disease. The patients participating in this study will take orally once daily xaliproden or placebo (inactive substance pill).

Alzheimer Disease

Sanofi1,306 participantsStarted Nov 2003

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +118 more locations

COMPLETEDPhase 3147 miles

SLV308 for Treatment of Patients With Early Parkinson's Disease

NCT00269516

This study is a multicenter, randomized, double blind, parallel group study of 6 months' treatment with SLV308 administered as a monotherapy in patients with early stage PD. An open label safety extension to this study is planned as a separate protocol for patients who are willing and eligible to participate.

Early Stage Parkinson's Disease

Solvay Pharmaceuticals468 participantsStarted Jun 2006

Huntsville, Alabama, United States • Little Rock, Arkansas, United States • Fountain Valley, California, United States +125 more locations

COMPLETEDPhase 1147 miles

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

NCT00000778

To evaluate the methodology for rapidly determining the early bactericidal activity (EBA), tolerance, and pharmacokinetics of isoniazid and levofloxacin in the treatment of pulmonary tuberculosis (TB). Traditionally, in trials for treatment of TB, a new drug is administered in combination with two or more other antituberculous agents of known effectiveness over a long period of time. In this setting, it is difficult to determine the effect of any single drug or dose level. Development of new agents for the treatment of TB may be accelerated by a methodology in which a new agent could be evaluated for activity by administering it as a single agent over a short time period. This study utilizes a method to measure the amount of bacteria present each day in the lungs.

HIV InfectionsTuberculosis

National Institute of Allergy and Infectious Diseases (NIAID)44 participants

Birmingham, Alabama, United States • Los Angeles, California, United States • Torrance, California, United States +7 more locations

COMPLETEDPhase 3147 miles

Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)

NCT00141193

This study is a prospective, randomized, double-blind, placebo-controlled, multi-center trial to compare the efficacy and safety of celecoxib 400mg QD versus placebo in reducing the occurrence of new colorectal adenomas post-polypectomy at Month 13 (Year 1) and Month 37 (Year 3) of study drug administration.

Colorectal Adenoma

Pfizer1,561 participantsStarted Feb 2001

San Diego, California, United States • San Kiego, California, United States • North Chicago, Illinois, United States +103 more locations

COMPLETEDPhase 3163 miles

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

NCT00104013

The purpose of this study is to assess xaliproden's potential capacity of slowing the deterioration of cognitive and global functions in patients with mild to moderate Alzheimer's disease. The patients participating in this study will take orally once daily xaliproden or placebo (inactive substance pill).

Alzheimer Disease

Sanofi1,455 participantsStarted Nov 2003

Mesa, Arizona, United States • Mesa, Arizona, United States • Peoria, Arizona, United States +38 more locations

COMPLETEDPhase 3172 miles

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

NCT00081796

The purpose of this clinical trial is to determine if RPR109881 is a better treatment than capecitabine (Xeloda) for advanced breast cancer in patients that no longer benefit from docetaxel and/or paclitaxel.

Breast CancerMetastases

Sanofi438 participantsStarted Apr 2004

Birmingham, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +184 more locations

COMPLETEDPhase 2182 miles

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

NCT00001132

The purpose of this study is to see if adding 1 drug to an anti-HIV drug combination early in treatment against HIV can lower the viral load (amount of HIV in the blood) to a level so low that it cannot be measured (undetectable). The drug that will be added to a treatment is abacavir (ABC). Many patients who take 3 anti-HIV drugs together are able to achieve very low viral loads, for example, viral loads below 50 copies/ml. However, some patients taking only 3 drugs are not able to achieve a viral load this low. Doctors hope that, by adding the drug ABC to a current treatment, a viral load below 50 copies/ml can be achieved. Doctors would like to find out if it is effective to start patients on 3 drugs and then add another drug (treatment intensification) if the treatment is not working as well as hoped.

National Institute of Allergy and Infectious Diseases (NIAID)80 participantsStarted Nov 1999

Los Angeles, California, United States • Menlo Park, California, United States • San Jose, California, United States +27 more locations

COMPLETEDPhase 3182 miles

Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters

NCT00322270

To evaluate the safety profile of alfimeprase as assessed by monitoring of adverse events, serious adverse events and major bleeding events for up to 120 minutes following the instillation of study drug to an occluded central venous access device.

ThrombosisVenous ThrombosisCatheter Occlusion

ARCA Biopharma, Inc.Started Jan 2006

Casa Grande, Arizona, United States • Soquel, California, United States • Boynton Beach, Florida, United States +15 more locations

TERMINATEDPhase 3182 miles

Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

NCT00322036

This is a multinational, randomized, double blind, placebo controlled, parallel group study comparing the safety and efficacy of daily dosing of 800 mg twice daily MPC-7869 to placebo. Study subjects will have the diagnosis of mild dementia of the Alzheimer's type. Subjects may be taking approved medication for Alzheimer's disease provided the dose has been stable for at least 6 months.

Alzheimer DiseaseDementia

Myrexis Inc.800 participantsStarted May 2006

Phoenix, Arizona, United States • Tucson, Arizona, United States • Costa Mesa, California, United States +89 more locations

COMPLETEDNA200 miles

Study for Evaluating Different Methods of Measuring Depression Treatment Response

NCT00406952

Purpose of the study is to evaluate use of electronic diaries and voice acoustics for use in future depression clinical trial. Focus is on increased precision of measurement.

Depressive Disorder, Major

Pfizer165 participantsStarted Nov 2006

Norwich, Connecticut, United States • Aventura, Florida, United States • Jacksonville, Florida, United States +9 more locations

COMPLETEDPhase 3621 miles

Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma

NCT00044811

The purpose of this study is to investigate the efficacy and safety of fexofenadine 120mg BID compared to placebo in the treatment of subjects with mild to moderate persistent asthma

Sanofi1,000 participantsStarted Mar 2002

Bridgewater, New Jersey, United States • Costa Rica, Costa Rica • Guatemala City, Guatemala +4 more locations

COMPLETEDPhase 3621 miles

Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma

NCT00044824

The purpose of this study is to investigate the efficacy and safety of fexofenadine 120mg BID compared to placebo in the treatment of subjects with mild to moderate persistent asthma

Sanofi1,000 participantsStarted Feb 2002

Bridgewater, New Jersey, United States • Costa Rica, Costa Rica • Guatemala City, Guatemala +4 more locations

COMPLETEDNA753 miles

Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss

NCT00471172

The aim of the study was to compare 5 methods of delivering a weight loss lifestyle modification program to obese patients on a background of sibutramine. The methods differed in the type and frequency of counseling utilized to deliver dietary, physical activity and behavioral recommendations for weight loss.

Pfizer350 participantsStarted Aug 2004

Los Angeles, California, United States • Clearwater, Florida, United States • Kissimmee, Florida, United States +9 more locations

COMPLETEDPhase 11007 miles

A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS

NCT00000966

To evaluate the effectiveness and toxicity of oral azithromycin and pyrimethamine as acute therapy for toxoplasmic encephalitis in AIDS patients. To assess the toxicity and effectiveness of azithromycin alone as maintenance therapy. Encephalitis caused by Toxoplasma gondii is the most frequent cause of focal central nervous system infection in patients with AIDS. Untreated, the encephalitis is fatal. Standard treatment for toxoplasmic encephalitis is associated with serious adverse effects. Thus, alternative treatments are needed.

Toxoplasmosis, CerebralHIV Infections

Pfizer45 participants

Los Angeles, California, United States • Miami, Florida, United States • Worcester, Massachusetts, United States +8 more locations

PreviousPage 743 of 761Next

Heart Diseasein Austin